The Ohio State University and Nationwide Children's Hospital invite you to the Second Annual Health Sciences Technology Showcase, featuring inventors from both institutions who will be presenting on solutions to leading issues within the healthcare industry. A reception and networking will follow the presentations.
With the demand for human breast milk on the rise, there exists a greater potential for contamination. A recent study found bovine contamination in over 10% of the breast milk samples tested. This technology detects bovine milk contamination in human breast milk.
A need exists for a device capable of preventing accidental injuries during oral surgery. This technology provides a disposable device designed to protect a patient’s lips from lacerations and burns.
The Ohio State and Nationwide Children's Hospital Vaccine Consortium: Mark Peeples, PhD, Nationwide Children's Hospital
The Ohio State and NCH Vaccine Consortium is an interconnected group of six expert virologists in human infection and immune response, genetic manipulation of viruses, and small animal vaccine testing. We have made major progress toward converting the current experimental respiratory syncytial virus (RSV) live attenuated vaccine into a functional, economically viable vaccine candidate. We have also developed, and continue to develop vaccines to protect livestock from diseases that threaten their economic viability.
Ultra-Violet Disinfection Lighting: Siddharth Rajan, PhD, The Ohio State University
Current sanitation procedures for surgical tools, hospital beds and equipment, water and air filtration systems, and the like, are costly, inefficient, and not environmentally friendly. Ultra-Violet Sanitation lighting effectively breaks down bacteria, viruses, mold and more, however, the cost of UV Sanitation is not feasible for most companies. Instead of using mercury lamps, this technology uses quantum mechanical tunneling to increase efficiency while reducing the cost of UV lighting by 50 times the average price.
Magnetic Resonance Elastography (MRE): Arun Kolipaka, PhD, The Ohio State University
Magnetic resonance elastography (MRE) is a new application of MRI technology that employs sound waves and gives the physician an estimate of the stiffness of body tissues via a visual map. MRE has found its first application in the diagnosis of liver disease. This invention offers the promise of extending MRE to other organs such as the heart, pancreas, prostate and spleen.
Novel Therapy for Scarring: David Brigstock, PhD, Nationwide Children's Hospital
There are currently no FDA-approved treatments for fibrosis, a pathological condition central to a variety of debilitating and potentially life-threatening disorders. This technology utilizes naturally-occurring cellular products called exosomes to reprogram fibrotic cells for treatment of liver fibrosis.